Comparison of 2SC, AKR1B10, and FH Antibodies as Potential Biomarkers for FH-deficient Uterine Leiomyomas

Terhi Ahvenainen; Jaana Kaukomaa; Kati Kämpjärvi; Outi Uimari; Anne Ahtikoski; Netta Mäkinen; Oskari Heikinheimo; Lauri A. Aaltonen; Auli Karhu; Ralf Bützow; Pia Vahteristo

doi:10.1097/PAS.0000000000001826

Comparison of 2SC, AKR1B10, and FH Antibodies as Potential Biomarkers for FH-deficient Uterine Leiomyomas

Terhi Ahvenainen, Jaana Kaukomaa, Kati Kämpjärvi, Outi Uimari, Anne Ahtikoski, Netta Mäkinen, Oskari Heikinheimo, Lauri A. Aaltonen, Auli Karhu, Ralf Bützow, Pia Vahteristo

Research output: Contribution to journal › Article › Scientific › peer-review

Original language	English
Journal	American Journal of Surgical Pathology
Volume	46
Issue number	4
Pages (from-to)	537-546
Number of pages	10
ISSN	0147-5185
DOIs	https://doi.org/10.1097/PAS.0000000000001826
Publication status	Published - Apr 2022
MoE publication type	A1 Journal article-refereed

Fields of Science

uterine leiomyoma
HLRCC
FH
2SC
FUMARATE-HYDRATASE GENE
RENAL-CELL CANCER
HEREDITARY LEIOMYOMATOSIS
GERMLINE MUTATIONS
IDENTIFY PATIENTS
FIBROIDS
MED12
INACTIVATION
SUCCINATION
FREQUENCY
3111 Biomedicine
3126 Surgery, anesthesiology, intensive care, radiology

Access to Document

10.1097/PAS.0000000000001826

Ahvenainen_Kaukomaa_Accepted_ManuscriptAccepted author manuscript, 176 KBLicence: CC BY-NC

Cite this

Ahvenainen, T., Kaukomaa, J., Kämpjärvi, K., Uimari, O., Ahtikoski, A., Mäkinen, N., Heikinheimo, O., Aaltonen, L. A., Karhu, A., Bützow, R., & Vahteristo, P. (2022). Comparison of 2SC, AKR1B10, and FH Antibodies as Potential Biomarkers for FH-deficient Uterine Leiomyomas. American Journal of Surgical Pathology, 46(4), 537-546. https://doi.org/10.1097/PAS.0000000000001826

@article{cde6ab2729fb4796a0abb68079af8b8e,

title = "Comparison of 2SC, AKR1B10, and FH Antibodies as Potential Biomarkers for FH-deficient Uterine Leiomyomas",

keywords = "uterine leiomyoma, HLRCC, FH, 2SC, FUMARATE-HYDRATASE GENE, RENAL-CELL CANCER, HEREDITARY LEIOMYOMATOSIS, GERMLINE MUTATIONS, IDENTIFY PATIENTS, FIBROIDS, MED12, INACTIVATION, SUCCINATION, FREQUENCY, 3111 Biomedicine, 3126 Surgery, anesthesiology, intensive care, radiology",

author = "Terhi Ahvenainen and Jaana Kaukomaa and Kati K{\"a}mpj{\"a}rvi and Outi Uimari and Anne Ahtikoski and Netta M{\"a}kinen and Oskari Heikinheimo and Aaltonen, {Lauri A.} and Auli Karhu and Ralf B{\"u}tzow and Pia Vahteristo",

year = "2022",

month = apr,

doi = "10.1097/PAS.0000000000001826",

language = "English",

volume = "46",

pages = "537--546",

journal = "American Journal of Surgical Pathology",

issn = "0147-5185",

publisher = "Wolters Kluwer Health",

number = "4",

}

Ahvenainen, T, Kaukomaa, J, Kämpjärvi, K, Uimari, O, Ahtikoski, A, Mäkinen, N, Heikinheimo, O , Aaltonen, LA , Karhu, A , Bützow, R & Vahteristo, P 2022, 'Comparison of 2SC, AKR1B10, and FH Antibodies as Potential Biomarkers for FH-deficient Uterine Leiomyomas', American Journal of Surgical Pathology, vol. 46, no. 4, pp. 537-546. https://doi.org/10.1097/PAS.0000000000001826

TY - JOUR

T1 - Comparison of 2SC, AKR1B10, and FH Antibodies as Potential Biomarkers for FH-deficient Uterine Leiomyomas

AU - Ahvenainen, Terhi

AU - Kaukomaa, Jaana

AU - Kämpjärvi, Kati

AU - Uimari, Outi

AU - Ahtikoski, Anne

AU - Mäkinen, Netta

AU - Heikinheimo, Oskari

AU - Aaltonen, Lauri A.

AU - Karhu, Auli

AU - Bützow, Ralf

AU - Vahteristo, Pia

PY - 2022/4

Y1 - 2022/4

KW - uterine leiomyoma

KW - HLRCC

KW - FH

KW - 2SC

KW - FUMARATE-HYDRATASE GENE

KW - RENAL-CELL CANCER

KW - HEREDITARY LEIOMYOMATOSIS

KW - GERMLINE MUTATIONS

KW - IDENTIFY PATIENTS

KW - FIBROIDS

KW - MED12

KW - INACTIVATION

KW - SUCCINATION

KW - FREQUENCY

KW - 3111 Biomedicine

KW - 3126 Surgery, anesthesiology, intensive care, radiology

U2 - 10.1097/PAS.0000000000001826

DO - 10.1097/PAS.0000000000001826

M3 - Article

SN - 0147-5185

VL - 46

SP - 537

EP - 546

JO - American Journal of Surgical Pathology

JF - American Journal of Surgical Pathology

IS - 4

ER -